Related Experiment Video
Updated: May 22, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
[Mental and neurocognitive diseases and diabetes mellitus (Update 2026)]
Heidemarie Abrahamian1, Alexandra Kautzky-Willer2, Angelika Rießland-Seifert3
1Endokrinologische Ordination, Wien, Österreich.
Abstract:
Diabetes mellitus is frequently associated with mental diseases. Depressive disorders are twice as frequent in patients with diabetes compared to the nondiabetic population. Other mental diseases that frequently occur with diabetes and prediabetes are cognitive impairment up to dementia, disturbed eating behavior, anxiety disorders, schizophrenia, bipolar disorders, attention deficit/hyperactivity disorder (ADHD) and borderline personality disorder. The unfavorable effects of these comorbidities on metabolism are lasting and are manifested as poorer metabolic control and increased microangiopathic and macroangiopathic complications. The aim of this position paper is to raise awareness of all medical specialists as well as all other professional groups and organizations involved in the topic of diabetes to achieve an intensification of the complex treatment interventions in affected patients. Positive effects would include a reduced incidence of diabetes mellitus in patients with mental disorders and a reduction of diabetes-specific complications, particularly cardiovascular morbidity and mortality, as well as an improved quality of life in individuals with diabetes and comorbid mental illness.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Dementia l: Introduction
Alzheimer Disease l: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
